
Opinions
Jim Cramer - Mad Money
Summit TherapeuticsSMMTDON'T BUYJan 31, 2025
$21.50
Stock price when the opinion was issued
$14.07
As of Jun 17, 2026. Market Open.
biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
Doesn't make money and is a risky spec.